COMPANY
Cyclo Therapeutics
Timeline
- Trial start Phase 2: A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease source ↗
- Trial start 3: Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1 source ↗
- Trial start Phase 1: Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C source ↗
- Trial start Phase 1: Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1) source ↗
- Trial start Phase 1/Phase 2: Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients source ↗
Clinical trials (lead sponsor) 6
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT04860960 | Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1 | 3 | Unknown status (ClinicalTrials.gov) | Jul 20, 2021 | 2025-06 (estimated) |
| NCT05607615 | A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease | Phase 2 | Unknown status (ClinicalTrials.gov) | Sep 23, 2022 | Mar 31, 2024 (estimated) |
| NCT02912793 | Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients | Phase 1/Phase 2 | Completed | Mar 20, 2017 | Mar 3, 2021 (actual) |
| NCT03893071 | Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C | Phase 1 | Unknown status (ClinicalTrials.gov) | May 23, 2019 | 2022-03 (estimated) |
| NCT02939547 | Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1) | Phase 1 | Completed | Oct 11, 2017 | Feb 10, 2020 (actual) |
| NCT03624842 | Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease | Not listed | No longer available | Not listed | Not listed |